A Pooled Analysis of 3 Phase II Trials of Salvage Nivolumab/Ipilimumab After Nivolumab in Renal Cell Carcinoma.
Nivolumab plus ipilimumab has demonstrated improved survival for treatment-naïve advanced clear...
Read MoreNov 13, 2023
Nivolumab plus ipilimumab has demonstrated improved survival for treatment-naïve advanced clear...
Read MoreNov 13, 2023
Apalutamide plus androgen-deprivation therapy (ADT) improved outcomes in metastatic...
Read MoreNov 13, 2023
Although adjuvant systemic therapy (AT) has demonstrated improved survival in patients with...
Read MoreNov 13, 2023
Acute myeloid leukemia (AML) is a hematological malignancy with high mortality rate. The treatment...
Read MoreNov 13, 2023
Antibodies against human neutrophil antigen (HNA) are involved in the pathogenesis of neonatal...
Read MoreNov 13, 2023
Glioblastoma multiforme (GBM), a highly aggressive tumor, poses significant challenges in...
Read MoreNov 13, 2023
Telephone and virtual triage services are becoming increasingly common in ambulatory oncology...
Read MoreNov 13, 2023
Difficulties with social functioning are common among survivors of pediatric brain tumors. Social...
Read MoreNov 13, 2023
Brain tumor segmentations are integral to the clinical management of patients with glioblastoma,...
Read MoreNov 13, 2023
Previsit decision aids (DAs) have promising outcomes in improving decisional quality, however, the...
Read MoreNov 13, 2023
Health care organizations considering adopting a conversation aid (CA), a type of patient decision...
Read MoreNov 13, 2023
Extended-spectrum β-lactamases-producing Escherichia coli, Klebsiella pneumoniae, and Proteus...
Read MoreNov 13, 2023
To investigate the impact of reducing Clinical Target Volume (CTV) to Planning Target Volume (PTV)...
Read MoreNov 13, 2023
Glanzmann thrombasthenia (GT) is a rare, autosomal recessive disorder of platelet glycoprotein...
Read MoreNov 13, 2023
Bovine alphaherpesvirus type 1 (BoAHV-1) is associated with respiratory and reproductive...
Read MoreNov 13, 2023
No residual disease (CC 0) following cytoreductive surgery is pivotal for the prognosis of women...
Read MoreNov 13, 2023
Ovarian cancer (OC) is a common malignancy in women of reproductive age. Circular RNAs (circRNAs)...
Read MoreNov 13, 2023
The potential for repeated ovulation and menstruation is thought to have provided a Darwinian...
Read MoreNov 13, 2023
Pelvic surgery for endometriosis is associated with a risk of bladder and digestive sequelae....
Read MoreNov 13, 2023
This study adapted the Chinese version of the Couple Skills Training intervention program to...
Read More